股份增持
Search documents
通化东宝药业股份有限公司关于控股股东增持公司股份结果公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-11-02 14:28
Core Viewpoint - The controlling shareholder, Dongbao Group, has announced a share buyback plan for Tonghua Dongbao Pharmaceutical Co., Ltd., expressing confidence in the company's future development and value recognition [1][2]. Summary by Sections Share Buyback Plan - Dongbao Group plans to increase its shareholding in Tonghua Dongbao starting from October 31, 2024, through centralized bidding on the Shanghai Stock Exchange, with a minimum increase of 1% of the total share capital (19,817,341 shares) and a maximum of 2% (39,634,681 shares) [1]. - The implementation period for the buyback plan is from October 31, 2024, to October 30, 2025, without a set price range, depending on stock price fluctuations and overall market trends [1]. Implementation Results - As of October 30, 2025, Dongbao Group has successfully increased its shareholding by 27,801,409 shares, amounting to 228 million yuan, which represents 1.42% of the current total share capital [2]. - The actual increase has exceeded the lower limit of the buyback plan [2]. Additional Information - The buyback plan complies with relevant laws and regulations, including the Securities Law and the Shanghai Stock Exchange listing rules [3]. - The implementation of this buyback plan will not affect the company's shareholding structure or lead to changes in the controlling shareholder [4].
杭氧股份:中信金融资产增持1.43%公司股份,持股比例达5%
Xin Lang Cai Jing· 2025-10-29 12:32
Core Viewpoint - The announcement indicates that China CITIC Financial Asset Management Co., Ltd. has increased its stake in Hangyang Co., Ltd. through a block trade, reflecting confidence in the company's future prospects and value [1] Summary by Sections - **Shareholding Increase** China CITIC Financial Asset Management Co., Ltd. acquired an additional 13,968,400 shares of Hangyang Co., Ltd., representing 1.43% of the total share capital [1] - **Post-Transaction Holdings** After this transaction, China CITIC Financial Asset Management holds a total of 48,917,667 shares, which constitutes 5.00% of the company's total share capital [1]
上海莱士血液制品股份有限公司关于股份回购完成暨回购实施结果的公告
Shang Hai Zheng Quan Bao· 2025-10-28 23:15
Core Viewpoint - Shanghai Laishi Blood Products Co., Ltd. has completed its share repurchase plan, acquiring a total of 69,081,952 shares, which represents 1.04% of the company's total share capital, with a total expenditure of approximately RMB 474.94 million [4][6]. Summary by Sections Share Repurchase Plan - The company approved a share repurchase plan on January 13, 2025, with a total budget between RMB 250 million and RMB 500 million, and a maximum repurchase price of RMB 9.55 per share [2][3]. - The repurchase period is set for 12 months from the approval date, with the possibility of early completion if certain conditions are met [2]. Implementation Details - The repurchase was executed from April 2, 2025, to October 28, 2025, through a centralized bidding method [4]. - The highest transaction price was RMB 7.09 per share, and the lowest was RMB 6.62 per share [4]. Compliance and Impact - The repurchase was conducted in accordance with relevant regulations, and the execution details aligned with the approved plan [5][12]. - The completion of the repurchase is not expected to significantly impact the company's financials, operations, or debt obligations, nor will it alter the company's control status [6]. Future Arrangements - The repurchased shares will be used for employee stock ownership plans or equity incentives, with no immediate changes to the total share capital [14]. - If the shares are not utilized within 12 months, they will be canceled, leading to a reduction in registered capital [15].
深圳清溢光电股份有限公司关于实际控制人控制的企业增持公司股份进展暨增持时间过半的公告
Shang Hai Zheng Quan Bao· 2025-10-28 21:46
Core Viewpoint - The actual controller of Shenzhen Qingyi Optoelectronics Co., Ltd. plans to increase its shareholding in the company, reflecting confidence in the company's future development and long-term investment value [2][3]. Group 1: Buyback Plan Overview - The buyback plan was initiated by AVA International Limited, controlled by the actual controllers of the company, with a planned investment between RMB 20 million and RMB 40 million [2]. - The buyback period started on April 15, 2025, and will last for 12 months [2]. Group 2: Progress of the Buyback Plan - As of October 28, 2025, AVA International Limited has acquired 313,793 shares, representing 0.10% of the total share capital, with a total investment of approximately RMB 8.4658 million [3]. - The buyback amount has not yet exceeded 50% of the lower limit of the planned investment [3][4]. Group 3: Future Actions and Considerations - The company will continue to monitor the market conditions and will proceed with the buyback plan as per the original schedule [4][5]. - There are no indications that the buyback plan will be terminated early [4].
厚普股份:王季文及其一致行动人拟累计增持30%股份
Xin Lang Cai Jing· 2025-10-20 14:17
Core Viewpoint - The company announced that its controlling shareholder, Wang Jiwen, along with associated parties, plans to increase their stake in the company through a specific issuance of A-shares, which will trigger a mandatory tender offer obligation due to the increased ownership exceeding 30% [1] Group 1 - Wang Jiwen and his associates, including Yanxin Group, Beijing Xingkai, and Zhuhai Abama, intend to subscribe to the company's A-shares, with a total increase in shareholding not exceeding 30% [1] - Following this issuance, Wang Jiwen and his associates will collectively hold more than 30% of the company's equity, thus triggering the obligation for a tender offer [1] - The acquirers have committed that the shares obtained through this issuance will not be transferred for 36 months from the completion date of the issuance, allowing them to avoid making a tender offer [1]
逾28亿元真金白银增持回购 券商提振投资者信心正忙
Zhong Guo Zheng Quan Bao· 2025-10-15 22:19
Core Insights - The enthusiasm for share buybacks and increases in holdings among A-share listed companies and their major shareholders remains strong since 2025, with significant amounts being repurchased and increased [1][2][3] Group 1: Share Buybacks - As of October 15, 2023, several listed brokerages, including Dongfang Securities and Xibu Securities, have repurchased shares totaling over 2.3 billion yuan, a significant increase compared to the previous year [1][2] - Hongta Securities has repurchased 221.69 million shares, accounting for 0.047% of its total share capital, with a total expenditure of approximately 20.01 million yuan [2] - Guotai Junan led the buyback efforts among brokerages, repurchasing 67.52 million shares for a total of 1.21 billion yuan, representing 0.383% of its total share capital [3] Group 2: Shareholder Increases - Major shareholders of listed brokerages are also increasing their holdings, with Huaneng Capital increasing its stake in Changcheng Securities by 6.37 million shares, amounting to approximately 50.17 million yuan [3][4] - Hubei Hongtai Group has increased its holdings in Tianfeng Securities by 179 million shares, representing 2.06% of the total share capital, with a total investment of 502 million yuan [4] Group 3: Investor Confidence and Value Management - Many brokerages are focusing on enhancing investor confidence through new annual action plans aimed at improving returns and establishing effective shareholder return mechanisms [5][6] - Longjiang Securities has outlined plans for value creation, maintenance, and communication to enhance its investment value and investor relations [6]
一周安徽上市公司要闻回顾(10.06-10.12)
Xin Lang Cai Jing· 2025-10-13 05:49
Group 1 - Shanying International has repurchased approximately 145 million shares, accounting for 2.65% of the total share capital, with a total expenditure of about 282 million yuan [1] - Jiangnan Chemical plans to publicly bid for 100% equity of Chongqing Shun'an Explosive Materials Co., Ltd. with a base price of 1 billion yuan [1] - Evert has completed a share reduction plan, with shareholder Dinghui Yuanlin reducing approximately 13.04 million shares, representing 2.5% of the total share capital [1] Group 2 - Wanlong Magnetic Plastic has signed an agreement to purchase 100% equity of Tian'en Electronics for approximately 235.36 million yuan, focusing on home appliance glass products [2] - Zhonghuan Environmental Protection announced a change in controlling shareholder and actual controller, with the stock resuming trading on October 10, 2025, after a suspension due to this change [2] - Xinbo Co., Ltd. received government subsidies totaling 25.52 million yuan for its subsidiary [2] Group 3 - Delixi Co., Ltd. has suspended trading due to a planned change in control, with the specifics still under negotiation [3] - Anhui Heli's shareholder, Forklift Group, has increased its stake by approximately 6.27 million shares, representing 0.7% of the total share capital, with an investment of about 100 million yuan [4]
浪潮电子信息产业股份有限公司关于回购公司股份的进展公告
Shang Hai Zheng Quan Bao· 2025-10-10 19:33
Core Viewpoint - The company has initiated a share repurchase plan and reported the progress of the repurchase and the completion of a shareholding increase plan by its parent company, Inspur Group [1][6]. Share Repurchase Progress - As of September 30, 2025, the company has repurchased a total of 625,100 shares, accounting for 0.04% of the total share capital, with a total transaction amount of 35,589,513.00 yuan, excluding transaction fees [2]. - The highest transaction price was 60.00 yuan per share, while the lowest was 53.71 yuan per share [2]. Compliance with Regulations - The share repurchase was conducted in accordance with relevant regulations, including the "Share Repurchase Rules for Listed Companies" and the "Self-Regulatory Guidelines for Listed Companies" [3][4]. - The company did not repurchase shares during periods that could significantly impact the trading price of its securities [3]. Shareholding Increase by Inspur Group - Inspur Group has completed its shareholding increase plan, acquiring a total of 1,607,400 shares, which is 0.11% of the total share capital, with an investment amount of 10,048.69 million yuan, excluding transaction fees [8][9]. - Prior to the increase, Inspur Group held 475,835,665 shares, representing 32.32% of the total share capital [9]. Shareholding Structure Post-Increase - After the completion of the increase, Inspur Group holds 471,683,570 shares, which is 32.04% of the total share capital, while the combined holdings of Inspur Group and its affiliate, Inspur Software Technology Co., Ltd., amount to 477,443,065 shares, or 32.43% of the total share capital [9][10].
上海君实生物医药科技股份有限公司关于控股股东、实际控制人之一兼董事长增持股份进展暨增持时间过半公告
Shang Hai Zheng Quan Bao· 2025-10-10 18:29
Core Viewpoint - The controlling shareholder and chairman of Shanghai Junshi Biosciences Co., Ltd., Mr. Xiong Jun, plans to increase his shareholding in the company by at least RMB 100 million over the next 12 months, with a minimum of RMB 50 million allocated for A-shares [2]. Group 1: Shareholding Increase Plan - Mr. Xiong intends to start the share purchase from April 12, 2025, using methods permitted by the Shanghai Stock Exchange and Hong Kong Stock Exchange, including but not limited to centralized bidding and block trading [2]. - As of October 11, 2025, the share purchase plan is more than halfway through, but Mr. Xiong has not yet made any purchases due to factors such as reporting windows, equity incentive matters, and funding arrangements [5]. - The plan remains unfulfilled, and Mr. Xiong will continue to seek opportunities to increase his shareholding during the implementation period [5]. Group 2: Shareholding Details - Mr. Xiong directly holds 87,856,618 shares in the company, which includes 87,854,018 A-shares and 2,600 H-shares, with the latter held by HKSCC NOMINEES LIMITED as a nominal holder [3]. - The shareholding percentage is calculated based on the company's total share capital of 1,026,689,871 shares [3][4]. Group 3: Risk Factors - The share purchase plan may face risks due to changes in capital market conditions or other unpredictable factors that could prevent the plan from achieving its intended outcomes [6][8]. - The implementation of the share purchase plan will not lead to changes in the company's controlling shareholder or actual controller [7].
四川宏达股份有限公司关于公司部分董事、高级管理人员增持股份计划实施完毕暨增持结果的公告
Shang Hai Zheng Quan Bao· 2025-10-09 19:00
Core Viewpoint - The announcement details the completion of a share buyback plan by certain directors and senior management of Sichuan Hongda Co., Ltd., reflecting their confidence in the company's future and long-term investment value [2][4]. Summary by Sections 1. Disclosure of Buyback Plan - Sichuan Hongda Co., Ltd. announced a share buyback plan on April 9, 2025, where certain directors and senior management intended to purchase shares worth between RMB 1.9 million and RMB 3.8 million over a six-month period starting from the announcement date [2]. 2. Implementation Results of the Buyback Plan - As of October 8, 2025, the buyback participants had acquired a total of 310,800 shares, representing 0.0118% of the company's total share capital, with a total expenditure of RMB 2.0434 million. The buyback plan has been completed, and the participants now hold a total of 463,800 shares, which is 0.0176% of the total share capital [2][3]. 3. Basic Information of Buyback Participants - The buyback participants are identified as having a concerted action relationship, indicating a coordinated effort in the share acquisition [3]. 4. Compliance and Regulatory Framework - The buyback plan adheres to relevant laws and regulations, including the Securities Law and the Management Measures for the Acquisition of Listed Companies, ensuring that it does not alter the control of the company [4].